Великобритания - английский - MHRA (Medicines & Healthcare Products Regulatory Agency)

baxter healthcare ltd - sodium chloride; potassium chloride; calcium chloride; sodium lactate - infusion - 6mg/1ml ; 400microgram/1ml ; 270microgram/1ml ; 3.17mg/1ml

Мальта - английский - Medicines Authority

baxter healthcare limited - sodium chloride; potassium chloride; magnesium chloride hexahydrate; sodium acetate trihydrate; sodium gluconate - solution for infusion - sodium chloride 5.26 g/l; potassium chloride 0.37 g/l; magnesium chloride hexahydrate 0.30 g/l; sodium acetate trihydrate 3.68 g/l; sodium gluconate 5.02 g/l - blood substitutes and perfusion solutions

Мальта - английский - Medicines Authority

baxter healthcare limited - sodium chloride; potassium chloride; magnesium chloride hexahydrate; sodium acetate trihydrate; sodium gluconate - solution for infusion - sodium chloride 5.26 g/l; potassium chloride 0.37 g/l; magnesium chloride hexahydrate 0.30 g/l; sodium acetate trihydrate 3.68 g/l; sodium gluconate 5.02 g/l - blood substitutes and perfusion solutions

Австралия - английский - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - glucose, quantity: 50 g/l; sodium chloride, quantity: 6 g/l; sodium lactate, quantity: 3.22 g/l; potassium chloride, quantity: 400 mg/l; calcium chloride dihydrate, quantity: 270 mg/l - injection, solution - excipient ingredients: water for injections - compound sodium lactate solution and 5% glucose is indicated as a source of water and electrolytes. it is also used in patients as a source of bicarbonate in the treatment of mild to moderate metabolic acidosis associated with dehydration or associated with potassium deficiency. these solutions are indicated as methods of intravenous drug delivery, if the drugs are compatible with the solutions.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - glucose, quantity: 50 g/l; sodium chloride, quantity: 6 g/l; sodium lactate, quantity: 3.22 g/l; potassium chloride, quantity: 400 mg/l; calcium chloride dihydrate, quantity: 270 mg/l - injection, solution - excipient ingredients: water for injections - compound sodium lactate solution and 5% glucose is indicated as a source of water and electrolytes. it is also used in patients as a source of bicarbonate in the treatment of mild to moderate metabolic acidosis associated with dehydration or associated with potassium deficiency. these solutions are indicated as methods of intravenous drug delivery, if the drugs are compatible with the solutions.

Мальта - английский - Medicines Authority

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - sodium chloride, potassium chloride, magnesium chloride, hexahydrate, sodium acetate, trihydrate, sodium gluconate - solution for infusion - sodium chloride 5.26 g/l potassium chloride 0.37 g/l magnesium chloride hexahydrate 0.30 g/l sodium acetate trihydrate 3.68 g/l sodium gluconate 5.02 g/l - blood substitutes and perfusion solutions

Кения - английский - Pharmacy and Poisons Board

ephedrine hcl - nasal drops - ephedrine hcl b.p 1.0 w/v - ephedrine combinations

Ирландия - английский - HPRA (Health Products Regulatory Authority)

rona laboratories limited - ephedrine mild silver protein sodium chloride -

Ирландия - английский - HPRA (Health Products Regulatory Authority)

rona laboratories limited - ephedrine mild silver protein sodium chloride -

Австралия - английский - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - phenylephrine hydrochloride, quantity: 10 mg/ml - injection, solution - excipient ingredients: water for injections; sodium citrate dihydrate; sodium metabisulfite; nitrogen; sodium chloride; citric acid - indications as at 01 jan 1991 : phenylephrine hydrochloride is intended for the maintenance of an adequate level of blood pressure during spinal and inhalation anesthesia and for the treatment of vascular failure in shock, shock-like states, and drug-induced hypotension, of hypersensitivity. it is also employed to overcome paroxysmal supraventricular tachycardia, to prolong spinal anesthesia, and as a vasoconstrictor in regional analgesia.